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Background: Thyroid hormones are essential for the maturation and functions of the central nervous system. Pain
sensitivity is related to the thyroid status. However, information on how thyroid hormones affect pain processing
and synaptic transmission in the anterior cingulate cortex (ACC) is limited. Nociceptive threshold and synaptic
transmission in the ACC were detected in the experimental hypothyroidism (HT) mice.
Results: HT was induced by methimazole and potassium perchlorate in distilled drinking water for 4 weeks. The
threshold of pain perception to hot insults, but not mechanical ones, decreased in hypothyroid mice. After treatment
with tri-iodothyronine (T3) or thyroxine (T4) for 2 weeks, thermal pain threshold recovered. Electrophysiological recordings
revealed enhanced glutamatergic synaptic transmission and reduced GABAergic synaptic transmission in the ACC.
Supplementation with T3 or T4 significantly rescued this synaptic transmission imbalance. In the same model, HT
caused the up-regulation of the GluR1 subunit of the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
and NR2B-containing N-methyl-D-aspartate receptors, but it down-regulated γ-aminobutyric acid A receptors in the
ACC. Supplementation with T3 or T4 notably recovered the levels of above proteins.
Conclusions: These results suggest that HT promotes hypersensitivity to noxious thermal, and that supplementation
with T3 or T4 rescues the imbalance between excitatory and inhibitory transmission in the ACC.
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The thyroid hormones tri-iodothyronine (T3) and thyrox-
ine (T4) are essential for the metabolic homeostasis of the
tissues. Moreover, these hormones are crucially involved
in the maturation and function of the central nervous
system [1]. Congenital hypothyroidism (HT) causes mental
retardation in children [2]. Adult onset of HT also de-
creases cognition and increases anxiety [3]. The pain
sensitivity has been documented to be related with thy-
roid status [4]. An adequate support of maternal thyroid
hormones may be required to ensure a normal nocicep-
tive function of offspring into adulthood [5]. However,* Correspondence: yangtian@fmmu.edu.cn; kfdou2014@163.com
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unless otherwise stated.information regarding the underlying mechanism of thyroid
hormones in affecting pain processing and synaptic trans-
mission in the anterior cingulate cortex (ACC), which is
highly involved in the pain modulation, is limited.
ACC is a critical brain region involved in learning,
memory, attention, and pain [6-9]. Recent studies using
different experimental approaches suggest that ACC has
important functions in processing pain-related informa-
tion in humans and in behavioral responses to noxious
stimuli or tissue injury in animals [10-12]. Moreover, an
ample group of neurotransmitters and chemical messen-
gers, including opioids, glutamate, GABA, and dopamine,
are involved in the modulation of pain by these cortical
structures. 3-iodothyronamine (T1AM) is an endogenous
derivative of thyroid hormones and is a rapid modulator
of behavior and metabolism [4]. Electrophysiological
experiments suggest that T1AM affects the response to
catecholamines and other neurotransmitters by function-
ing as a specific inhibitor of dopamine, noradrenalinehis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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icles [13]. Therefore, T1AM might be regarded as a
neuromodulator.
The balance between excitatory and inhibitory transmis-
sion is critical for brain functions. The prolonged disturb-
ance of this balance can promote pathological anxiety-like
behaviors [14] and nociceptive responses [15]. Enhanced
excitatory and reduced inhibitory synaptic transmissions
contribute to persistent pain-induced neuronal hyper-
responsiveness in the ACC [16]. Studies have often dem-
onstrated the function of the ACC in the modulation of
anticipatory nociceptive responses aimed at avoidance of
potential danger, without changing nociceptive motor re-
sponses [17], and the modulation of responses to aversive
emotional content, which demonstrates its broad function in
many types of emotional processing [18]. In present study,
we found that drugs-induced HT promoted hypersensitivity
to noxious thermal but not mechanical stimulus, and that
supplementation with T3 or T4 reversed the imbalance be-
tween excitatory and inhibitory transmission in ACC.
Results
T3 and T4 levels in the serum
Methimazole (MMI) and 1% potassium perchlorate
(KClO4) treatment for 4 weeks significantly reduced the
serum free levels of T3 and T4 (Figure 1B and C). Sup-
plementation with T3 significantly increased the serum
levels of T3, but not T4. However, supplementation with
T4 significantly increase the serum levels of T3 and T4
in the MMI and KClO4 treated mice.
Pain threshold in the male hypothyroid mice
The thyroid hormone receptors were highly expressed in
the brain. First, we investigated the effect of experimentalFigure 1 Levels of T3 and T4 in serum. (A) Timeline for experiment.
Mice were treatment with MMI and KClO4 for 4 weeks, then followed
with T3 or T4 supplementation for 2 weeks. Detections were performed
during Day 43 and Day 45. Levels of T3 (B) and T4 (C) in saline control,
vehicle-, T3-, and T4-treated HT mice. n = 5 in each group. * p < 0.05,
** p < 0.01 compared with naïve saline control; ## p < 0.01 compared
with vehicle-treated HT mice.HT on the nociceptive threshold. Paw withdrawal latency
(PWL) was detected by investigating the latency to licking
of mice. MMI and KClO4 treatment for 4 weeks signifi-
cantly reduced the threshold of pain perception to hot
insults (Figure 2A). The succeeding treatment with T3 or
T4 for 2 weeks recovered the paw-withdraw latency in the
hypothyroid mice (Figure 2A). However, mechanical pain
threshold did not differ in the hypothyroid mouse model
and supplementation with T3 or T4 (Figure 2B). These
data indicate that thermal pain sensitivity is related to the
thyroid status but not to mechanical pain.Enhanced glutamatergic transmission in the ACC of
hypothyroid mice
The ACC is involved in pain processing [6,9]. To exam-
ine the function of the thyroid hormone in the balance
between excitation and inhibition, we performed whole-cell
patch-clamp recordings to record synaptic transmission in
the ACC pyramidal neurons. Treatment with MMI and
KClO4 induced the increase of glutamatergic transmis-
sion in the ACC as shown by the increase of frequency
(Figure 3C and D) or amplitude of mEPSCs (Figure 3E
and F). Supplementation with T3 or T4 significantly re-
duced the frequency and amplitude of mEPSCs in the ACC
pyramidal neurons of the hypothyroid mice (Figure 3D
and F). The kinetics of mEPSCs were not altered among
the neurons from the saline control, vehicle-, T3-, and
T4-treated hypothyroid mice (Figure 3B). However, bath
perfusion of T3 (4 nM) or T4 (40 nM) did not alter the
frequency and amplitude of mEPSCs in the ACC pyramidal
neurons of the naïve mice (Figures 3G and H). Increase in
the mEPSCs frequency suggests the enhanced presynaptic
release probability in the hypothyroid mice.Decreased inhibitory synaptic transmission in the ACC of
hypothyroid mice
To further examine the function of thyroid hormone
in the balance between excitation and inhibition, we
recorded mIPSCs in the ACC pyramidal neurons. Treat-
ment with MMI and KClO4 induced the decrease of
GABAergic transmission in the ACC, as demonstrated
by the decrease in frequency (Figure 4A, and C–D) or
amplitude of mIPSCs (Figure 4E and F). Supplementa-
tion with T3 or T4 significantly induced the frequency
and amplitude of mIPSCs in the ACC pyramidal neu-
rons from hypothyroid mice (Figure 4D and F). The kin-
etics of mIPSCs were not altered among the neurons
from the saline control, vehicle-, T3-, and T4-treated
hypothyroid mice (Figure 4B). Similar to the effects on
mEPSCs, bath perfusion of T3 (4 nM) or T4 (40 nM)
did not alter the frequency and amplitude of mIPSCs in
the ACC pyramidal neurons of the naïve mice (Figure 4G
and H).
Figure 2 Decreased pain threshold in hypothyroid mice. (A) Thermal threshold was shown as PWL in saline control, vehicle-, T3-, and T4-treated HT
mice. (B) Mechanical pain threshold in saline control, vehicle-, T3-, and T4-treated HT mice. n = 5 in each group. # p< 0.05 compared with vehicle-treated
HT mice.
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glutamate receptor up-regulation
To further determine the contribution of postsynaptic com-
ponent to the enhanced glutamatergic transmission in the
ACC of the hypothyroid mice, we detected the expression
of glutamate receptors by Western blot (Figure 5A). Treat-
ment with MMI and KClO4 induced the up-regulation of
GluR1 (Figure 5B) and NR2B (Figure 5D) subunits in the
ACC. Supplementation with T3 or T4 reversed GluR1 and
NR2B up-regulation (Figures 5B and D). However, NR2A
subunit was not altered in the ACC from hypothyroid mice
and T3/T4 supplemented hypothyroid mice (Figure 5D).
Supplementation with thyroid hormone reverses GABAA
receptor down-regulation
GABAA receptors are composed of α, β, and γ subunits.
GABAA receptor containing α2 subunit is highly repre-
sented in frontal cortex [19]. Treatment with MMI and
KClO4 induced a significant decrease in the expression
of GABAA-α2 in the ACC (Figure 6A and B). Supple-
mentation with T3 or T4 reversed the GABAA-α2 down-
regulation (Figure 6B). These results demonstrate that
the replacement of thyroid hormones reverses the
down-regulation of GABAA receptor expression in the
hypothyroid mice.
Discussion
This study provides strong evidence for the function of
thyroid hormones in pain processing. Adult onset of HT
promotes hypersensitivity to noxious thermal but not
mechanical stimulus. The hypersensitivity to noxious
thermal in HT is relieved by T3 or T4 replacement. The
underlying mechanisms of hormone therapy are presumed
to maintain a balance between glutamatergic and GABAer-
gic transmission in the ACC of hypothyroid mice.
HT and pain
In vertebrates, the thyroid secretes predominantly T4,
which has to be converted into the active hormone T3
and is responsible for most of the T3 supply within thebrain [20]. T3 and T4 bind three members of the nuclear
receptor superfamily: TRα1, TRβ1, and TRβ2 [21]. These
receptors regulate gene transcription by both ligand-
dependent and ligand-independent means [22]. The
thyroid hormone receptors are highly expressed in the
brain and have critical roles in brain development and
high functions [1,2]. Pain sensitivity is related to the
thyroid status [4]. The present study found that HT in-
creases hypersensitivity to noxious thermal but not mech-
anical stimulus. The hot-plate thermal model could be
interpreted as a behavioral reaction to emotional content,
which is produced in a state of acute pain and in a scenario
wherein the animal cannot escape from the source of
stimulation. Studies have shown the function of the ACC
in the modulating nociceptive responses aimed at avoiding
potential danger [17]. ACC has also been implicated in the
modulation of responses to aversive emotional processing
[15]. HT produces depression and anxiety in rodent
and patients [23,24]. This result may partially explain
the hypersensitivity to noxious thermal stimulus in the
hypothyroid mice.
Thyroid hormones, ACC synaptic transmission and plasticity
ACC is a critical brain region involved in processing
pain-related information in humans and in behavioral
responses to noxious stimuli or tissue injury in animals
[10-12]. In the present study, we found that synaptic
transmission was altered in the ACC synapses in the
hypothyroid mice. We also established that the replace-
ment of thyroid hormone could reverse the synaptic al-
terations. The adult onset of HT prevents the generation
of experimentally evoked early and long-term potentiation
in the hippocampal CA1 region of the rat, which is associ-
ated by the changes in the expression of NR1 glutamater-
gic receptor subunits [25,26]. These findings indicate that
thyroid hormones affect nociceptive responses, at least
partially, through regulating the synaptic transmission in
the ACC. Previous studies have showed the increased
quantal release of excitatory transmitter in anterior cingu-
late cortex of adult mice with chronic pain [27,28]. Our
Figure 3 Enhanced glutamatergic synaptic transmission in the
ACC. (A) Sample mEPSCs recording in pyramidal neurons at a
holding potential of −70 mV from each group. (B) Left, average
mEPSC of events from saline (52 events), vehicle- (67 events), T3-
(61 events), and T4- (57 events) treated HT mice; Right, Time constant
of mEPSC decay (τ) versus the rising time (10 –90%) in the recordings
from saline control (n = 10 slices/5 mice), vehicle- (n = 9 slices/5 mice),
T3- (n = 9 slices/5 mice), and T4- (n = 8 slices/5 mice) treated HT mice.
(C) Cumulative frequency histogram of the mEPSCs from the slices in
each group. (D) Summery of mEPSCs frequency in neurons from saline
control, vehicle-, T3-, and T4-treated HT mice. (E) Cumulative amplitude
histogram of the mEPSCs from the slices in each group. (F) Summery
of mEPSCs amplitude in neurons from control, vehicle-, T3-, and
T4-treated HT mice. (D) and (F): Number of recordings from control
(n = 11 neurons/5 mice), vehicle- (n = 10 neurons/5 mice), T3- (n = 9
neurons/5 mice), and T4- (n = 8 neurons/5 mice) treated HT mice.
* p < 0.05 compared with saline control; # p < 0.05 compared with
vehicle-treated HT mice. (G) Sample mEPSCs recording in pyramidal
neurons at a holding potential of −70 mV from naïve mice.
(H) Summery of mEPSCs frequency (left) amplitude (right) in neurons
perfused with saline (n = 8 neurons/4 mice), T3 (n = 10 neurons/4 mice),
and T4 (n = 8 neurons/4 mice).
Figure 4 Reduced GABAergic synaptic transmission in the ACC.
(A) Sample mIPSCs recording in pyramidal neurons at a holding
potential of 0 mV from each group. (B) Left, average mIPSC of
events from saline (89 events), vehicle- (97 events), T3- (82 events),
and T4- (94 events) treated HT mice; Right, Time constant of mIPSC
decay (τ) versus the rising time (10 –90%) in the recordings from
saline control (n = 8 slices/5 mice), vehicle- (n = 8 slices/5 mice), T3-
(n = 9 slices/5 mice), and T4- (n = 10 slices/5 mice) treated HT HT
mice. (C) Cumulative frequency histogram of the mIPSCs from the
slices in each group. (D) Summery of mIPSCs frequency in neurons
from saline control, vehicle-, T3-, and T4-treated HT mice. (E)
Cumulative amplitude histogram of the mIPSCs from the slices in
each group. (F) Summery of mIPSCs amplitude in neurons from
saline control, vehicle-, T3-, and T4-treated HT mice. (D) and
(F): Number of recordings from control (n = 9 neurons/5 mice), vehicle-
(n = 11 neurons/5 mice), T3- (n = 10 neurons/5 mice), and T4- (n = 9
neurons/5 mice) treated HT mice. * p < 0.05 compared with control;
# p < 0.05 compared with vehicle treated-HT mice. (G) Sample mIPSCs
recording in pyramidal neurons at a holding potential of 0 mV from
naïve mice. (H) Summery of mIPSCs frequency (left) amplitude (right)
in neurons perfused with saline (n = 8 neurons/4 mice), T3 (n = 9
neurons/4 mice), and T4 (n = 9 neurons/4 mice).
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Figure 5 Expression of glutamate receptors. (A) Representative western-blot analysis of GluR1, NR2A, and NR2B subunits in the ACC homogenates.
Levels of GluR1 (B), NR2A (C), and NR2B (D) in saline control, vehicle-, T3-, and T4-treated HT mice. n = 5 in each group. * p < 0.05, ** p < 0.01
compared with saline control; # p < 0.05 compared with vehicle-treated HT mice.
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more, we found that the acute perfusion of T3 or T4 in
the brain slices did not induce the alterations in the
frequency and amplitude of mEPSCs and mIPSCs. As
mentioned above, thyroid hormone receptors are nu-
clear receptors and regulate gene transcription by both
ligand-dependent and ligand-independent means [22].Figure 6 Expression of GABAA receptor. (A) Representative
western-blot analysis of GABAA-α2 subunit in the ACC homogenates.
(B) Levels of GABAA-α2 in saline control, vehicle-, T3-, and T4-treated
HT mice. n = 5 in each group. * p < 0.05, ** p < 0.01 compared with
saline control; # p < 0.05, ## p < 0.01 compared with vehicle-treated
HT mice.Thyroid hormone replacement therapy occurs through
gene transcription and protein expression.
Thyroid hormones and the balance between excitatory
and inhibitory transmission
Excitatory and inhibitory transmission homeostasis is
critical for brain functions [14,15]. Enhanced excitatory
and reduced inhibitory synaptic transmissions contribute
to persistent pain-induced neuronal hyper-responsiveness
in the ACC [16]. Systemic or ACC local administration of
Ro25-6981, which is a specific NR2B receptors antagonist,
significantly reduces behavioral allodynia [11]. In the
present study, we found that HT induced the up-regulation
of GluR1 and NR2B-containing NMDA receptors and the
down-regulation of α2-containing GABAA receptors in
the ACC. GABAA receptors consist of α, β, and γ sub-
units. GABAA receptors containing α1-, α2-, β1-3, and
γ2-subunits are highly represented in frontal cortex
[29]. α2-containing GABA(A) receptor, representing
approximately 15-20% of all GABAA receptors, is consid-
ered as a target for the development of novel treatment
strategies for CNS disorders, such as anxiety, depression,
schizophrenia, and chronic pain. Western blot data indi-
cated that the replacement of T3 or T4 reversed the levels
of GluR1, NR2B-containing NMDA receptors and α2-
containing GABAA receptors in the hypothyroid mice.
Combining these data with electrophysiological recordings,
we could further confirm the glutamatergic and GABAergic
synaptic transmission changes induced by thyroid hor-
mones. We did not exclude the possible alterations of
other GABAA subunits in the hypothyroid mice.
ACC is well known for its critical in the pain processing,
including the chronic inflammatory pain, neuropathic
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present study, we found the parallel changes of nociceptive
behavior and electrophysiology in HT mice and rescued by
T3 and T4. Furthermore, the changes in E/I imbalance
was found in the HT mice. Actually, enhancement of
GABAergic transmission is a useful therapeutic strategy
for the pain relief [34,35]. Thus, restoring the E/I imbalance
in ACC may contribute to decrease the hypersensitivity
after supplementation with T3 or T4. Indeed, we could
exclude the possible changes of E/I imbalance in other
pain-related brain regions of HT mice, such as insular
cortex, amygdala, and somatosensory cortex.
Conclusions
In summary, this study investigated the novel mecha-
nisms underlying thyroid status and nociceptive pro-
cessing. Thyroid hormone replacement is associated
with restoring the balance between excitatory and inhibi-
tory transmission in the ACC of HT. This phenomenon
indicates that a signal transduction mechanism is neces-
sary for neuronal function under both physiological and
pathological conditions. Accordingly, improved under-




All chemicals and reagents were purchased from Sigma
(St. Louis, MO) unless otherwise stated. Rabbit anti-NR2A
and anti-NR2B were purchased from Millipore (Billerica,
MA). Rabbit anti-GluR1 was purchased from Abcam
(Cambridge, UK). Rabbit anti-GABAA-α2 antibody was
purchased from Alomone labs (Jerusalem, Israel). All of
the chemicals and reagents used were commercially
available and of standard biochemical quality.
Animals and treatment
Male C57BL mice, aged 7 to 8 weeks obtained from the
Laboratory Animal Center of the Fourth Military Medical
University (FMMU), were used in all the experiments. An-
imals were housed in groups of 4, with food and water
available ad libitum. The room was maintained at con-
trolled temperature (24 ± 2°C), humidity (50 – 60%). Mice
were allowed to adapt to laboratory conditions for at least
1 week before procedures were performed. All animal
experiments were carried out in accordance with the
National Institutes of Health Guide for the Care and
Use of Laboratory Animals (NIH Publications No. 80–23,
revised 1978) to minimize animal suffering. The Fourth
Military Medical University Animal Care and Use
Committee approved the animal protocols. To established
hypothyroidism, mice were administered with 0.05%
methimazole (MMI) and 1% potassium perchlorate (KClO4)
in distilled drinking water for 6 weeks [24]. From week 4,some of mice were supplemented with T3 (0.5 μg/ml) or
T4 (5 μg/ml) for 2 weeks. T3 and T4 hormones were
added in drinking water. Behavioral testing, electrophysio-
logical recording, and western-blot were performed be-
tween Day 43 and Day 45 (Figure 1A).
Thermal threshold
The hot-plate test was used to measure the response
latencies in mice according to the previously described
method [36]. The mice were screened by placing them
on a hot metal plate maintained at 50 ± 0.05°C. The
paw withdrawal latency (PWL) was defined as the time
to start jumping, withdrawal of the paws or the licking
of the paws. The mice were selected for the experiment
which offered response within 20 s. The cut-off time
was set at 30 s to minimize skin damage.
Mechanical threshold
Mice were placed in individual plastic boxes and allowed to
adjust to the environment for 30 min. Using the up-down
paradigm [37], mechanical sensitivity was assessed with a
set of von Frey filaments (0.04–15 g) applied perpendicu-
larly to the midplantar surface of the hind paws. Based on
preliminary experiments that characterized the threshold
stimulus, the innocuous 0.4 g (#3.61) filament, representing
50% of the threshold force, was used to detect mechanical
threshold. The filament was applied to the point of bending
six times each to the dorsal surfaces of the injected hind
paws. Positive responses included prolonged hind-paw
withdrawal followed by licking or scratching. For each
time point, the percentage response frequency of hind-paw
withdrawal was expressed as follows: (number of positive
responses)/6 × 100 per hind-paw.
Thyroid measurements
T3 and T4 levels in the plasma were detected using the
ELISA kit (IBL, MN) following the manufacturer’s in-
structions. Briefly, the mice were anesthetized with
diethyl ether. The eyeballs of mice were removed by
ophthalmological forceps to break the blood vessels of the
fundus oculi. Blood (about 1.0 mL every mouse) was col-
lected in the 2.0 ml centrifuge tube. Blood was centrifuged
at 12000 rpm at 4°C for 15 min and the supernatant was
collected for ELISA.
Electrophysiological recordings
Coronal brain slices (300 μm), containing the ACC, were
prepared as previously described [9]. Slices were trans-
ferred to submerged recovery chamber with oxygenated
(95% O2 and 5% CO2) artificial cerebrospinal fluid (ACSF)
containing (in mM): 124 NaCl, 2.5 KCl, 2 CaCl2, 2 MgSO4,
25 NaHCO3, 1 NaH2PO4, 10 glucose at room temperature
for at least 1 h. Experiments were performed in a recording
chamber on the stage of an Axioskop 2FS microscope with
Yi et al. Molecular Pain 2014, 10:38 Page 7 of 8
http://www.molecularpain.com/content/10/1/38infrared DIC optics for visualization of whole-cell patch
clamp recording. Miniature postsynaptic currents (mEPSCs
and mIPSCs) were recorded from layer II–III neurons with
an Axon 200B amplifier (Axon Instruments, CA) with
0.5 μM TTX in the ACSF. AMPA receptor mediated
mEPSCs were recorded in the neurons clamped at
−70 mV. The recording pipettes (3–5 MΩ)? were filled
with solution containing (mM) 145 K-gluconate, 5
NaCl, 1 MgCl2, 0.2 EGTA, 10 HEPES, 2 Mg-ATP, and
0.1 Na3-GTP (adjusted to pH 7.2 with KOH). GABAA
receptor-mediated mIPSCs were recorded in the neu-
rons clamped at 0 mV with CNQX (20 μM) and AP-5
(100 μM) in the ACSF. The patch electrodes contained
102 mM cesium gluconate, 5 mM TEAchloride, 3.7 mM
NaCl, 11 mM BAPTA, 0.2 mM EGTA, 20 mM HEPES,
2 mM MgATP, 0.3 mM NaGTP, and 5 mM QX-314 chlor-
ide (adjusted to pH 7.2 with CsOH). Access resistance was
15–30 MΩ? and monitored throughout the experiment.
Data were discarded if access resistance changed more
than 15% during an experiment.Western-blot analysis
Western-blot analysis was performed as previously de-
scribed [38]. Tissue samples from the ACC were dis-
sected from brain slices (300 μm) under an anatomical
microscope. ACC samples from 5 mice were analyzed
by Western-blot. Equal amounts of protein (50 μg) were
separated and electrotransferred onto PDVF membranes
(Invitrogen), which were probed with antibodies against
GluR1 (dilution ratio 1:300), NR2A (dilution ratio 1:200),
NR2B (dilution ratio 1:500), and GABAA-α2 (dilution ratio
1:200) with β-actin (dilution ratio 1:10000) as the loading
control. The membranes were incubated with horseradish
peroxidase–conjugated secondary antibodies (anti-rabbit/
anti-mouse IgG for the primary antibodies). The densito-
metric analysis of the Western-blot was conducted using a
ChemiDoc XRS (Bio-Rad, Hercules, CA) and quantified
using Quantity One version 4.1.0 (Bio-Rad) according to
the instructions. For data quantification, band intensity of
each blot was calculated as ratio relative to β-actin. The
intensity ratio of the control group was set as 100%, and
the intensity of other treatment groups were expressed as
percentage to the control group.Statistical analysis
Results were expressed as the mean ± SEM. Data were
evaluated using one-way analysis of variance (ANOVA)
for post hoc comparisons (SPSS 13.0). Data that passed
the homogeneity test were analyzed by the one-way
ANOVA Least Significant Difference (LSD) test. Data
that did not pass the homogeneity test were analyzed
by the one-way ANOVA Dunnett’s T3 test. In all cases,
p < 0.05 was considered statistically significant.Abbreviations
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